Edwards Benchmark program, a peer-to-peer educational program, is based on a set of validated care pathways that could deliver significant quality of life improvement1 and meaningful hospital savings2 through:

Risk-stratified case selection
Streamlined peri-procedural approaches
Standardized post-procedure protocols for transfemoral transcatheter valve replacement.
Male doctor researching on laptop

Edwards Benchmark Program targets 6 meaningful clinical outcomes

1% 30-day Mortality3
1% 30-day Stroke3
1% 30-day Major Vascular Complications1
6% 30-day Permanent Pacemaker Implants4
4% 30-day Cardiac Readmissions3
80% Next-Day Discharge Home4

Watch a patient journey through Edwards Benchmark program

Edwards Benchmark program brochure with infographics

Edwards Benchmark program best practices

For patients and ICs — risk-stratified case selection1,2
A more efficient pre-procedure experience
Streamlined evidence-based peri-procedural protocols1,2
Achieve excellent clinical outcomes
Standardised post-procedural protocols1,2
Safe early discharge, improved Quality of Life
Bringing together the TAVI community worldwide
Best practice sharing, in pursuit of higher standards and goals
View Edwards Benchmark program brochure
Male interventional cardiologist researching on his laptop

How TAVI demonstrates excellent patient safety outcomes without additional resource usage

View evidence from the 3M study3

See the 2021 EuroPCR Benchmark symposium

Watch symposium

For more information email us at Benchmark_EU@edwards.com

Stay informed with our newsletter


1. Lauck, S.B.; Wood, D.A.; Baumbusch, J.; et al. Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of Stay. Circ Cardiovasc Qual Outcomes 2016;9:312-321.
2. Butala N. Economics of minimalist TAVR: The 3M TAVR Economic Study. TCT presentation 2021.
3. Barbanti, M; van Mourik, M.S.; Spence, M.S.; et al. Optimizing Patient Discharge Management after Transfemoral Transcatheter Aortic Valve Implantation: The Multicentre European FAST- TRANSCATHETER AORTIC VALVE IMPLANTATION Trial. EuroIntervention 2019;15(2):147-154.
4. Wood, D.A.; Lauck, S.B.; Cairns, J.A.; et al. The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-volume Transfemoral Transcatheter Aortic Valve Replacement Centers: the 3M TAVR Study. J Am Coll Cardiol Intv 2019;12:459-469.

For professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable). Edwards devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

PP--EU-3358 v1.0